Friday, May 9, 2025
Home Tags Hapbee

Tag: Hapbee

Hapbee
Telehealth

Hapbee (HAPB) Provides Update. Over 1,800 Devices Delivered.

Editor / Curator -
Hapbee, Biotech Stock Review
All News

Hapbee Technologies (HAPB): Updates and News Archive.

Editor / Curator -
Hapbee, Biotech Stock Review
Telehealth

Hapbee (HAPB) Soars 136% the First Day of Trading!

Editor / Curator -
Hapbee,
All News

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

Editor / Curator -
Hapbee, Biotech Stock Review
Biotech News

Video: Hapbee Testimonials.

Editor / Curator -
Internet Stock Review
Internet News

Peleton (PTON) Hits $25 Billion Valuation. Calm (Private) Hits Unicorn Valuation...

Editor / Curator -
Biotech News

Hapbee Closes $6.5 Million Private Placement and Provides Corporate Update.

Editor / Curator -
hAPBEE, bIOTECH sTOCK rEVIEW
All News

Whitepaper: Effects of Magnetic Fields on Biological Systems

Editor / Curator -
Hapbee
All News

Augmentative Wearable Device, Hapbee, Receives Amazing Reviews by Testers.

Editor / Curator -
Biotech News

Hapbee Corporate Presentation. Private.

Editor / Curator -
12Page 2 of 2

Latest article

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is...

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.